Patient-Centered Measurement: Innovation Challenge Series

Similar documents
The Pharmacy Quality Alliance Optimizing Health by Advancing the Quality of Medication Use

Progress from the Patient-Centered Outcomes Research Institute (PCORI)

Quality Metrics & Immunizations

Integrating the Patient Perspective Into Value Frameworks

Telligen Quality Innovation Network Quality Improvement Organization

Presenters: Robin Newhouse Steven Goodman David Hickam

Introduction to the Patient- Centered Outcomes Research Institute

IMPACT APA STRATEGIC PLAN

Increasing Adult Immunization Rates in the US Through Data and Quality: A Roadmap

HEALTH INFORMATION TECHNOLOGY: A POWERFUL TOOL IN ATTACKING THE OPIOID CRISIS PAUL L. UHRIG CHIEF ADMINISTRATIVE, LEGAL & PRIVACY OFFICER

Accelerating Patient-Centered Outcomes Research and Methodological Research

Medicare Star Ratings and the Shift to Quality- Based Payment Models. David Nau, RPh, PhD, FAPhA PQS President

Colorectal Cancer Screening in Washington State

NATIONAL QUALITY FORUM

NQF Serious Illness Initiative Quality Measurement Committee

The Academy Capitol Forum: Meet the Experts. Diagnosing Which Health Treatments Improve Outcomes: A PCORI Overview and How to Get Involved

TRANSFORMING RESEARCH FINDINGS INTO ACTION: BUILDING A COMMUNICATIONS STRATEGY TO PROMOTE CHANGE AT THE LOCAL, REGIONAL, & STATE LEVEL

A New Approach to Assessing Family Engagement in Health Care Systems. Webinar January 23, 2019 at 10 am PST

NHC Webinar Series on Clinical Outcome Assessments. Patient-Reported Outcomes and Patient-Centered Outcomes: Is There a Difference?

THE NATIONAL QUALITY FORUM

ABOUT LUNG CANCER ALLIANCE

Strategic Plan: Implementation Work Plan

Ministry of Health and Long-Term Care. Palliative Care. Follow-Up on VFM Section 3.08, 2014 Annual Report RECOMMENDATION STATUS OVERVIEW

NQF All-Member Call. Dial-In: Webinar link:

PCORI and PCOR. David R. Flum, MD MPH

Executive Women s Breakfast Patient Advocacy Real Trust, Real Partnerships for Real Innovation

PCORI s Role in Supporting CER

Over 425 Members Strong

Consumer Participation Strategy

Cancer Action Coalition of Virginia Report to the Governor, General Assembly, and the Joint Commission on Health Care.

Chief Development Officer National Brain Tumor Society

Research CP Overview Webinar #1

Research Collaborations: Lessons from PeDRA and the SPD

PCPI Update Progress on Strategic Initiatives

Family History & Early Onset Colorectal Cancer Task Group

Understanding How the U.S. Preventive Services Task Force Works USPSTF 101

SUNDAY, MARCH 24 TUESDAY, MARCH 26, 2019 THE MAYFLOWER HOTEL, WASHINGTON, DC 20 Y E A R S CELEBRATING 20 YEARS OF QUALITY

Title: Antipsychotic Use in Persons with Dementia CMS ID: ARCO3 NQF #: N/A

Multiple Chronic Conditions: A New Paradigm for Approaching Chronic Disease

DENTAL QUALITY ALLIANCE: 2018 ANNUAL MEASURES REVIEW

Engaging with FDA: A Guide for Foundation Funders of Research. FasterCures Webinar Series presents. April 18, 2012

Capital Health Plan CMS Star Ratings Strategies for Improvement

Good Participatory Practice guidelines

ACHP Orientation. Getting the most from your membership

Pursuing Quality Lives

Edward Jones, MD KCP Chairman Gail Wick, MHSA, BSN, RN, CNN Allen Nissenson, MD

Port of Portland Hillsboro Airport Master Plan Update Planning Advisory Committee Charter

1201 Maryland Avenue SW Suite 900 Washington, DC

RE: Draft CMS Quality Measure Development Plan: Supporting the Transition to the Merit-based Incentive Payment System and Alternative Payment Models

Collective Impact in Health

NATIONAL VOLUNTARY CONSENSUS STANDARDS: PALLIATIVE CARE AND END-OF-LIFE CARE A CONSENSUS REPORT FINAL REPORT

Impact of the Cancer Prevention and Control Research Network April 2018

ViiV Healthcare Positive Action for Youth 2019 Amp Grant Program Lead Request for Proposals

Thank you for your continued engagement and member support of the Pharmacy Quality Alliance.

Jayna Holroyd-Leduc, MD, FRCPC Associate Professor, Section of Geriatrics, U of Calgary Co-Chair of TVN s Citizen Engagement Initiative

DEVELOPMENTS IN THE CLINICAL TRIALS ENVIRONMENT Two Initiatives February 27, 2014

This webinar/paper/report/product/etc. was developed [in part] under contract number HHSS I/HHS T from the Substance Abuse and

Oncology Clinical Pathways: Making Treatment Decisions in the Era of Patient-Centered, Personalized Cancer Care June 12, 2017

Canadian Prairies Chapter of HIMSS is Coming to Town. December 17, 2018

What is a Special Interest Group (SIG)?

Palliative and End-of-Life Care

PRESENTATION. Conference Proceedings. RAND Medicare Advantage (MA) and Part D Contract Star Ratings Technical Expert Panel May 31st 2018 Meeting

AMCP Webinar Series. Exchanges and Qualified Health Plans: How your voice can shape the future of quality reporting 14 January 2014.

Coalition for Access and Opportunity Fast Track Medicaid for SNAP Participants. April 23, 2014

TYPE IN THE CHAT. Please type your name, organization, and city/state into the chat.

ACO Congress Conference Pre Session Clinical Performance Measurement

MEMBERSHIP REPORT A MESSAGE FROM THE EXECUTIVE DIRECTOR MEMBERSHIP

HEALTH AND SPORT COMMITTEE AGENDA. 14th Meeting, 2018 (Session 5) Tuesday 1 May 2018

Dementia Priority Setting Partnership. PROTOCOL March 2012

Treatment of Multiple Sclerosis

WCO ACTION PLAN FOR THE ECONOMIC COMPETITIVENESS PACKAGE

Lia Hotchkiss: I'm Lia Hotchkiss and I'm with the Agency for Healthcare. Research and Quality. We are one of the 12 agencies part of the Department of

An Active Inclusive Capital. A Strategic Plan of Action for Disability in London

At the Intersection of Public Health and Health Care: CDC s National Asthma Control Program

STRATEGIC PLAN

Chapter Quality Network (CQN) Practice Improvement to Address Adolescent Substance Use Project Chapter Application

A Perspective from the Co-Chairs of the: National Quality Forum Prevention Endorsement Maintenance Steering Committee

Moving Beyond Cooperation: Engaging Families in Health Care Organizations and Practices Thursday, May 25, Noon Central

Agenda for the Metastatic Breast Cancer (MBC) Engagement Conference at Moffitt Cancer Center. June 22-23, 2018

OCTOBER EOEA and the Alzheimer s Association have organized implementation of the plan around its five major recommendations:

Preparing Our State for Alzheimer s Disease and Related Dementias

Patient-Centered Cancer Treatment Planning: Improving the Quality of Oncology Care

Better Health Partnership Update

PQS Summary of Pharmacy/ Medication-Related Updates in the CY 2020 Final Call Letter

Mental Health Matters

2012 AAHPM & HPNA Annual Assembly

Professional Education and Practice Implementation Task Group

PARTNERS FOR A HUNGER-FREE OREGON STRATEGIC PLAN Learn. Connect. Advocate. Partners for a Hunger-Free Oregon. Ending hunger before it begins.

Maximizing Your Medicare Star Ratings

WASHINGTON STATE PLAN TO ADDRESS ALZHEIMER S DISEASE AND OTHER DEMENTIAS

Addressing Gaps in MS Care. November 6, :00 AM - Noon

2017 Executive Summary. The Conrad N. Hilton Foundation s Youth Substance Use Prevention and Early Intervention Strategic Initiative

Gathering and Using Member Feedback in Plan Governance

Fifth Annual National ACO Summit

ANNUAL REPORT 2014 FINDING CONNECTIONS FINDING A CURE

Transforming health through IT

Breakout: Quality and Performance Measure WG

A Framework for Patient-Centered Outcomes Research

From CF Adult and Family Advisors (AFA) to Community Voice

Research for Development Impact Network

Transcription:

Patient-Centered Measurement: Innovation Challenge Series Learning Collaborative 2018 Webinar Thursday, March 1, 2018 1

Hala Durrah, MTA Patient Family Engagement Consultant, Speaker & Advocate 3 2017-18 Learning Collaborative Patient-Centered Measurement Webinar Series Overview Share Principles for Making Health Care Measurement Patient-Centered Identify novel solutions through 2017 Innovation Challenge Co- Created Comprehensible & Timely Patient- Driven Patient- Centered Measurement Holistic Transparent Graphic courtesy of American Institutes for Research. 4 2

2017 Innovation Challenge Winning Submissions Sameer Saini, MD, MS, VA Ann Arbor Center for Clinical Management Research and University of Michigan Institute for Healthcare Policy and Innovation Discusses measures of colorectal cancer screening that incorporate individual screening benefit and patient preferences Matthew Pickering, PharmD, RPh,, and Eleanor Perfetto, PhD, MS, National Health Council Share a proposed rubric to assess the patient-centeredness of measure development and implementation 5 Today s Presenters Sameer Saini, MD, MS, VA Ann Arbor Center for Clinical Management Research and University of Michigan Institute for Healthcare Policy and Innovation Matthew Pickering, PharmD, RPh, Pharmacy Quality Alliance Eleanor Perfetto, PhD, MS, National Health Council 6 3

Developing a Patient-Centered Measure of CRC Screening Sameer D. Saini, MD, MS Research Scientist, VA Ann Arbor Center for Clinical Management Research Associate Professor, University of Michigan Medical School Overview 1. Existing approaches to CRC quality measurement 2. Data from prior and ongoing work 3. Proposed approach to patient-centered measure development 4

Background Colorectal cancer is the 2 nd leading cause of cancerrelated death in the United States. Prevention and early detection through screening has been shown to reduce CRC mortality. As a result, the USPSTF recommends that all average-risk adults undergo routine screening from age 50-75. CRC Screening Use Over Time 65% QMs Medicare 28% HEDIS Katie Couric Advocacy and Public Health 5

Background In parallel, policy makers have developed measures to assess underuse of CRC screening. The HEDIS measure for CRC screening was first introduced by NCQA in 2003. This widely used underuse measure assesses proportion of individuals aged 50-75 who are up to date for screening. The Gap Age alone is not a sufficient criterion for making a screening decision: USPSTF: Clinicians should always understand the evidence but individualize decision-making to the specific patient and situation. But HEDIS uses age without explicitly considering clinical differences between patients in the target age group. 6

CRC Screening PM Objective Develop a measure that: Incorporates individual patient benefit Considers patient preferences Feasible to implement 7

Saini, et al. JAMA. 2014 Dec 3;312(21):2211-2. Screening benefit can be quantified for an individual patient, and it varies considerably between people of the same age. 8

50% Effect of HEDIS Measure Adjusted Screening Completion by Age 40% Screening Completion 30% 20% 10% 0% 50 55 60 65 70 75 80 Age Adjusted for gender, health status, and number of primary care visits Effect of HEDIS Measure 50% Relationship Between Age, Health Status, and Screening Completion Screening Completion 40% 30% 20% 10% Excellent Health Moderate Health Poor Health 0% Age 50-69 Age 70-75 Age > 75 PM Cutoff Saini, et al. BMJ. 2014;348:g1247. 9

Effect of HEDIS Measure 50% Screening Completion: Age 75 versus Age 76 Screening Completion 40% 30% 20% 10% Excellent Health Moderate Health Poor Health 0% Age 75 Age 76 Saini, et al. BMJ. 2014;348:g1247. Effect of HEDIS Measure 50% Screening Completion: Age 75 versus Age 76 OR = 1.95 (95% CI: 1.53-2.47) Screening Completion 40% 30% 20% 10% Excellent Health Moderate Health Poor Health 0% Age 75 Age 76 Saini, et al. BMJ. 2014;348:g1247. 10

How comfortable would you be with stopping if you had serious life-limiting health problems? 50% 40% 30% 29% 20% 10% 8% 9% 14% 12% 16% 13% 0% Saini, et al. Gastroenterology. 2013; 144 (5 Suppl 1): S-579. 50% How comfortable would you be with stopping if your doctor recommended (due to low benefit)? 40% 30% 30% 20% 10% 9% 11% 12% 12% 14% 11% 0% 11

Screening Orders 2/26/2018 Empowering Patients 100% 75% 77% 74% 70% 62% 60% 50% 51% 25% 0% Low Benefit Medium Benefit High Benefit Control Decision Aid Overview of Proposed Work We will specify several individualized, patientcentered measures of CRC screening performance. Candidate measures will be presented to an advisory panel of patients and an advisory panel of experts. Panels will be asked to assess measures on prespecified characteristics and provide additional feedback. 12

Proposed Work The existing HEDIS measure uses a single target rate for the entire screen-eligible population. The use of a single target rate fails to account for important heterogeneity in the screening population. To address this issue, we will modify the target rate: Use quantitative estimates of benefit from simulation models Use preferences of older adults (aged 70-75) who have been systematically informed in a clinical trial Proposed Work We will use several approaches to calculate tailored target rates: 1. Proportion of systematically informed patients in the trial who chose to undergo screening 2. Stratify this rate by health status and prior screening history. 3. Stratify this rate by the expected benefit of screening. Each approach will yield an increasingly refined target rate for the population. 13

Proposed Work After conducting measure specification and analyses, we will convene two advisory panels: Patient panel: 8-10 patients, ages 50-85 Expert panel: 8-10 healthcare providers and policy makers and measure developers Proposed Work Panelists will be presented with data from candidate measures and asked to discuss: Whether the measures are meaningful How the various approaches are likely to be perceived by patients Feasibility of implementation Unintended effects Time for open-ended feedback and additional measure specification. 14

Acknowledgments Funder: VA Health Services Research and Development Study Team: VA Ann Arbor Center for Clinical Management Research Erasmus University Medical Center Memorial Sloan Kettering Cancer Center University of Colorado School of Medicine Thank you for your attention! 15

Optimizing Health by Advancing the Quality of Medication Use A Rubric to Evaluate Patient Centeredness in Quality-Measure Development Matthew K. Pickering, PharmD Director, Research & Quality Strategies Eleanor M. Perfetto, PhD, MS Senior Vice President, Strategic Initiatives National Health Council Measuring Healthcare Quality and Performance 32 16

Deep Thought 1. How do we decide what to measure? 2. How do we know that what we are measuring is patient-centered? 3. How do we know what truly matters to patients? 33 About the (PQA) Optimizing health by advancing the quality of medication use Created in 2006 as a public-private partnership Multi-Stakeholder, Member-Based, Non-Profit Transparent & Consensus-Based Process Nationwide Measure Developer 34 17

PQA Measures in Medicare Part D Star Ratings 2018 Part D Star Ratings Measures Measure ID Measure Weight D12 Medication Adherence for Diabetes Medications 3 D13 Medication Adherence for Hypertension (RAS antagonists) 3 D14 Medication Adherence for Cholesterol (Statins) 3 D15 MTM Program Completion Rate for CMR 1 PQA measures significantly contribute to a plan s Star rating due to the heavy weighting of the intermediate outcome measures. 35 About the National Health Council (NHC) The voice of the 133 million people in the US with chronic disease and disability National, membership organization Almost 100 years old, founded in 1920 Members are predominantly patient groups, which control its governance Other members include: non-profits dedicated to health, professional organizations, trade groups, business and industry Advocates for cross-cutting issues affecting patients 36 18

PQA s Measure Development Process Patient & Caregiver Advisory Panel (PCAP) IV. Measure Testing III. Member Comment II. Development V. Endorsement I. Measure Concept VI. Evaluation 37 Methods for Engaging the Patient Community in Quality Measure Development Patient/Caregiver advisory panel(s) Focus groups Working groups One-on-one interviews Surveys Virtual community Blueprint for the CMS Measures Management System Version 13.0. CMS.gov Centers for Medicare and Medicaid Services. https://www.cms.gov/medicare/quality-initiatives-patient-assessment-instruments/mms/mms-blueprint.html. Updated 24 August 2017. 38 19

The Patient-Centered Challenge How to assess patient centeredness in quality measure development? Identified Priorities from the Patient Community Perceived challenges to meaningful patient-community engagement in quality measure-development 1 : Closed out of some segments of the process Brought into the process after much of the work is completed Asked to represent the views of all patients Identified Priority from Patient Community Increase patient-community skills and capacity to engage in quality Develop tools to support the patient community in engagement on quality Proposed Solution Develop a rubric to evaluate patient centeredness in quality-measure development Implement and encourage the use of the rubric Identify emerging good practices for patient centeredness in measure development Defined as a tool with criteria and levels of achievement in patient centeredness and patient engagement Concannon TW, Friedberg MW, Hwang A, and Wiitala K. Engaging Consumers in the Quality Measurement Enterprise. Santa Monica, CA: RAND Corporation, 2017. https://www.rand.org/pubs/research_reports/rr1760.html. 40 20

Existing Patient-Engagement Rubrics & Frameworks Describe best practices for patient engagement in measure development 1 Guidance on how to incorporate patient engagement into the research process 2 Rubric to evaluate patient centeredness of healthcare value models 3 How do we evaluate patient engagement in measure development? 1. Blueprint for the CMS Measures Management System Version 13.0. CMS.gov Centers for Medicare and Medicaid Services. https://www.cms.gov/medicare/quality-initiatives-patient-assessment-instruments/mms/mms-blueprint.html. Updated 24 August 2017. 2. PCORI Engagement Rubric. PCORI (Patient-Centered Outcomes Research Institute) website. http://www.pcori.org/sites/default/files/engagement-rubric.pdf. Published February 4, 2014. Updated June 6, 2016. 3. The Patient Voice in Value: National Health Council Patient-Centered Value Model Rubric. National Health Council Website. http://www.nationalhealthcouncil.org/sites/default/files/value-rubric.pdf. Published March 2016. 41 Executing this Idea How will we develop & implement a patientengagement rubric for quality measure development? 21

Development & Implementation Phase I: Development Phase II: Implementation Convene a multi-stakeholder Advisory Roundtable to develop the rubric Identify and describe the characteristics of meaningful patient engagement in measure development Convene a larger stakeholder group to socialize and inform effective implementation of the rubric Implement the rubric within PQA s measure development cycle Disseminate and encourage the use of the rubric, where possible 43 What this Could Look Like Figure 1. PQA s Measure Development Process Measure Concept Idea Measure Concept Development Draft Measure Testing Measure Endorsement Measure Update Domain 1: Measure Concept Generation and Prioritization Characteristics of Meaningful Patient Engagement Measure concept(s) important to patients are identified and included into prioritization considerations Examples of Achievement Levels High A clear link was described between the prioritized measure concepts and importance to patients Low Prioritized measure concepts were considered without the considering patient views 44 22

Optimizing Health by Advancing the Quality of Medication Use A Rubric to Evaluate Patient Centeredness in Quality-Measure Development Matthew K. Pickering, PharmD Director, Research & Quality Strategies Eleanor M. Perfetto, PhD, MS Senior Vice President, Strategic Initiatives National Health Council Audience Question & Answer 46 23

Wrap Up & Announcements 47 2017-18 Learning Collaborative Patient-Centered Measurement Webinar Series Focus on Patient-Centered Healthcare Measurement Stay tuned for the final webinar in this series Watch previous webinars in this series February 8, 2018 January 23, 2018 September 25, 2017 August 30, 2017 48 24

2017-18 Learning Collaborative Patient-Centered Measurement Webinar Series Focus on Patient-Centered Healthcare Measurement Register for NQF s Annual Conference, March 12-13 in Washington, DC, for a special session, NQF Measure Incubator Past, Present, and Future To learn more, please contact NQF at incubator@qualityforum.org Share your ideas with us #ptvoice #ptcenteredmeasures 49 25